Merck’s Molnupiravir paper in NEJM, imputed values study From TrialSiteNews By Leo Goldstein December 20, 2021 This adds details to Merck’s Molnupiravir paper in NEJM contains fabricated data and corrects reasoning about the Annex, Table S6. Table S6 has the same baseline viral load value 6.81 (on log10 scale) in both Molnupiravir and Placebo arms....